LSPN Spring: ‘Fascinating’ UPC is a ‘wake-up call’ for US lawyers

10x Genomics injunction showed the need to take the court ‘really seriously’ says US lawyer | With a focus on efficiency and plaintiff-friendly measures, the UPC's impact on patent valuations and litigation strategies is becoming increasingly apparent, at LSPN Spring.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Unified Patent Court

WATCH: The Unified Patent Court — two years on the frontline

9 December 2025 Will James and Tim Harris, Osborne Clarke, discuss their experiences litigating life sciences cases before the UPC and share key insights from the court’s early decisions.

Unified Patent Court

Regeneron and CureVac: UPC ‘cannot be ignored’

4 November 2025 Growing clout, powerful remedies, and efficiency are making the UPC a game-changer in global litigation, according to LSPN Europe experts. Tom Phillips reports.

Unified Patent Court

WATCH: UPC update—shaping patent litigation

4 August 2025 Powell Gilbert experts share insights on how the Unified Patent Court is taking shape after two years in operation, in this session from LSPN.

More features

Novartis bets $2bn on biologics as Xolair patents fade

WIPR debuts Global In-House Elite 2026

mRNA litigation: Who’s winning, who’s filing, and what’s next

Dechert boosts litigation bench with partner duo

UK court deals blow to Spanish pharma’s SPC bid for contraceptive

EPO reports record patent filings, but pharma and biotech lag

Part II: The race to replace semaglutide heats up

Part I: Ozempic goes generic as Novo’s key patent expires

LSPN Spring: ‘Fascinating’ UPC is a ‘wake-up call’ for US lawyers

More on this story

Editor's picks

Editor's picks

More features